Geode Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $36.1K | Sell |
|
|||||
|
2024
Q3 | $57.9K | Sell |
|
|||||
|
2024
Q2 | $147K | Buy |
|
|||||
|
2024
Q1 | $258K | Hold |
|
|||||
|
2023
Q4 | $144K | Hold |
|
|||||
|
2023
Q3 | $263K | Buy |
|
|||||
|
2023
Q2 | $316K | Hold |
|
|||||
|
2023
Q1 | $357K | Hold |
|
|||||
|
2022
Q4 | $327K | Buy |
|
|||||
|
2022
Q3 | $930K | Buy |
|
|||||
|
2022
Q2 | $790K | Sell |
|
|||||
|
2022
Q1 | $2.29M | Buy |
|
|||||
|
2021
Q4 | $1.68M | Sell |
|
|||||
|
2021
Q3 | $3.86M | Buy |
|
|||||
|
2021
Q2 | $5.09M | Buy |
|
|||||
|
2021
Q1 | $541K | Buy |
|
|||||
|
2020
Q4 | $166K | Buy |
|
|||||
|
2020
Q3 | $79K | Sell |
|
|||||
|
2020
Q2 | $167K | Hold |
|
|||||
|
2020
Q1 | $264K | Buy |
|
|||||
|
2019
Q4 | $213K | Buy |
|
|||||
|
2019
Q3 | $443K | Buy |
|
|||||
|
2019
Q2 | $347K | Buy |
|
|||||
|
2019
Q1 | $382K | Buy |
|
|||||
|
2018
Q4 | $67K | Hold |
|
|||||
|
2018
Q3 | $325K | Buy |
|
|||||
|
2018
Q2 | $318K | Buy |
|
|||||
|
2018
Q1 | $373K | Buy |
|
|||||
|
2017
Q4 | $463K | Buy |
|
|||||
|
2017
Q3 | $118K | Hold |
|
|||||
|
2017
Q2 | $165K | Sell |
|
|||||
|
2017
Q1 | $255K | Buy |
|
|||||
|
2016
Q4 | $205K | Buy |
|
|||||
|
2016
Q3 | $247K | Hold |
|
|||||
|
2016
Q2 | $186K | Hold |
|
|||||
|
2016
Q1 | $183 | Hold |
|
|||||
|
2015
Q4 | $305K | Buy |
|
|||||
|
2015
Q3 | $275K | Buy |
|
|||||
|
2015
Q2 | $759K | Buy |
|
|||||
|
2015
Q1 | $614K | Buy |
|
|||||
|
2014
Q4 | $603K | Buy |
|
|||||
|
2014
Q3 | $1.51M | Buy |
|
|||||
|
2014
Q2 | $1.26M | Buy |
|
|||||
|
2014
Q1 | $1.19M | Buy |
|
|||||
|
2013
Q4 | $679K | Buy |
|
|||||
|
2013
Q3 | $700K | Buy |
|
|||||
|
2013
Q2 | $713K | Buy |
|